Almost 3.4M traded today!!!, page-26

I agree that it is painful watching DNA deep in the red, but it needs to be kept in perspective.  I feel the company is undervalued (the reasons are given in DNA research).  These sort of fluctuations are perfectly normal when cheap companies become cheaper.  I have an average buy price of 47cents and I am down several thousand but as long as the company performs this does not bother me much (although of course I would love to be purchasing now instead).
I am also quite pleased to see Ben Reichel purchasing $100,000 or so in stock.  At least this is an amount that will actually start to mean something.  I don’t put much stock (no pun intended!) in director purchases of $10,000 or so.

My personal view is not to sell unless I see an announcement that changes my fair value or unless the SP moves above my fair value range (not much chance of this happening at the moment).  It should be noted that this is a prime tax loss candidate and with the possibility PM capital is moving out the heavy selling may continue.